Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Holtzman

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Advances in Radiation Oncology|November 2, 2019
Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma SurvivorsAdam L Holtzman, John M Stahl, Simeng Zhu, et al.
Craniomaxillofacial Trauma & Reconstruction|February 22, 2021
Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell CarcinomaWilliam M Mendenhall, Adam L Holtzman, Roi Dagan, et al.
Journal of Neurological Surgery. Part B, Skull Base|June 30, 2022
Impact of Type of Treatment Center and Access to Care on Mortality and Survival for Skull Base Chordoma and ChondrosarcomaAdam L Holtzman, James E Bates, Christopher G Morris, et al.
Journal of Neuro-Oncology|February 23, 2020
Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort studyMichael S Rutenberg, Ronny L Rotondo, Dinesh Rao, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2022
The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignanciesAdam L Holtzman, Michael S Rutenberg, Alexandra N De Leo, et al.
Head & Neck|January 24, 2025
Survival, Tumor Control, and Safety Outcomes of Proton Therapy in Sinonasal Cancer Population: A Systematic Review and Meta-AnalysisSrivatsa Surya Vasudevan, Estephania Candelo, Alireza Sharifi, et al.
Journal of Neuro-Oncology|January 24, 2023
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningiomaAdam L Holtzman, Gabriella E Glassman, Roi Dagan, et al.
Journal of Neuro-Oncology|March 12, 2022
Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution SeriesMichael S Rutenberg, Adam L Holtzman, Daniel J Indelicato, et al.
Head & Neck|August 11, 2022
Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapyAlexandra N de Leo, Roi Dagan, Christopher G Morris, et al.
International Journal of Particle Therapy|July 21, 2021
Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base ChordomaAdam L Holtzman, Ronny L Rotondo, Michael S Rutenberg, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Advances in Radiation Oncology|November 2, 2019
Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma SurvivorsAdam L Holtzman, John M Stahl, Simeng Zhu, et al.
Craniomaxillofacial Trauma & Reconstruction|February 22, 2021
Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell CarcinomaWilliam M Mendenhall, Adam L Holtzman, Roi Dagan, et al.
Journal of Neurological Surgery. Part B, Skull Base|June 30, 2022
Impact of Type of Treatment Center and Access to Care on Mortality and Survival for Skull Base Chordoma and ChondrosarcomaAdam L Holtzman, James E Bates, Christopher G Morris, et al.
Journal of Neuro-Oncology|February 23, 2020
Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort studyMichael S Rutenberg, Ronny L Rotondo, Dinesh Rao, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2022
The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignanciesAdam L Holtzman, Michael S Rutenberg, Alexandra N De Leo, et al.
Head & Neck|January 24, 2025
Survival, Tumor Control, and Safety Outcomes of Proton Therapy in Sinonasal Cancer Population: A Systematic Review and Meta-AnalysisSrivatsa Surya Vasudevan, Estephania Candelo, Alireza Sharifi, et al.
Journal of Neuro-Oncology|January 24, 2023
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningiomaAdam L Holtzman, Gabriella E Glassman, Roi Dagan, et al.
Journal of Neuro-Oncology|March 12, 2022
Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution SeriesMichael S Rutenberg, Adam L Holtzman, Daniel J Indelicato, et al.
Head & Neck|August 11, 2022
Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapyAlexandra N de Leo, Roi Dagan, Christopher G Morris, et al.
International Journal of Particle Therapy|July 21, 2021
Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base ChordomaAdam L Holtzman, Ronny L Rotondo, Michael S Rutenberg, et al.
Pageof 4